![Takeda Pharmaceutical Co Ltd (PK)](/common/images/company/NO_TKPHF.png)
Takeda Pharmaceutical Co Ltd (PK) (TKPHF)
USOTC
Fin d'année 31 Mars 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Return on Assets (%) | 2.81 | 4.417 | 1.214 | 0.331 | 2.922 | 1.764 | 2.337 | 0.991 |
Return on Equity (%) | 5.805 | 9.424 | 3.039 | 0.895 | 7.592 | 4.237 | 5.267 | 2.114 |
Return on Invested Capital (%) | 13.209 | 9.001 | 17.408 | 5.554 | 6.125 | 8.293 | 8.416 | 8.042 |
Operating Margin (%) | 8.713 | 12.835 | 7.954 | 3.113 | 16.184 | 12.463 | 13.004 | 5.267 |
Net Profit Margin (%) | 6.636 | 10.555 | 5.203 | 1.344 | 11.758 | 6.446 | 7.871 | 3.379 |
Book Value Per Share | -176.57 | -32.847 | -2465.283 | -2192.629 | -1754.546 | -1607.057 | -1709.99 | -1523.456 |
Earnings Per Share | 145.398 | 235.169 | 69.729 | 28.065 | 238.523 | 145.4 | 200.353 | 91.042 |
Cash Per Share | 404.107 | 370.613 | 448.62 | 404.481 | 612.934 | 537.016 | 337.187 | 289.305 |
Working Capital Per Share | -133.366 | 429.475 | 344.872 | 186.208 | 596.12 | 283.085 | -53.075 | 155.128 |
Operating Profit Per Share | 1766.029 | 1833.093 | 1126.442 | 1801.337 | 1806.369 | 1947.654 | 2193.734 | 2265.09 |
EBIT Per Share | 181.331 | 273.321 | 60.636 | -38.54 | 232.325 | 191.228 | 237.054 | 33.361 |
EBITDA Per Share | 181.331 | 273.321 | 60.636 | -38.54 | 232.325 | 191.228 | 237.054 | 33.361 |
Free Cash Flow Per Share | 185.239 | 346.92 | 117.021 | -24.095 | 213.476 | 73.122 | 358.501 | 121.885 |
Fin d'année 31 Mars 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 790,52M | 794,69M | 1,57B | 1,58B | 1,58B | 1,58B | 1,58B | 1,58B |
Capitalisation boursière | 39,53B |
Ratio cours/bénéfice | 0,53 |
Ratio prix/ventes | 0,02 |
Ratio prix/liquidités | 0,17 |
Ratio prix/valeur comptable | 0,01 |
Rendement de dividende | 67 142,86% |
Actions en circulation | 1,56B |
Volume moyen (1 semaine) | 244 |
Volume moyen (1 mois) | 30,61k |
Variation sur 52 semaines | -3,45% |
Plus haut sur 52 semaines | 30,90 |
Plus bas sur 52 semaines | 23,80 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales